Skip to main content
. 2015 Oct 14;27(6):1830–1836. doi: 10.1681/ASN.2015040426

Table 2.

Short- and long-term effects of frequent in–center hemodialysis on left ventricular mass and the physical health composite score

Variable/Tx Unadjusted Changeb from Baseline to Extension (±SD) |N| Adjusted Means and Treatment Effectsc (±SEs or 95% CIs) [P Value]
Observed Dataa Mean±SD |N| Month 12 Extension
Baseline Month 12 Extension Change from Baseline Treatment Comparison (Six Versus Three Times) Change from Baseline Treatment Comparison (Six Versus Three Times)
Left ventricular mass (g)
 Three times 142.0±53.1 |120| 138.1±51.5 |84| 137.6±50.7 |29| −8.6±19.1 |28| −2.4±3.1 −13.7 (−21.7 to −5.6) [<0.001] −5.4±3.6 −8.7 (−17.9 to 0.5) [0.06]
 Six times 139.8±55.3 |125| 125.5±46.0 |101| 124.0±43.8 |33| −12.6±32.9 |33| −16.0±2.9 −14.1±3.4
Physical health composite score (SF36)
 Three times 38.1±9.7 |120| 38.5±9.3 |93| 37.7±10.3 |44| −0.5±8.4 |43| 0.2±0.9 3.2 (0.9 to 5.4) [<0.01] −0.6±1.1 0.2 (−2.6 to 3.1) [0.87]
 Six times 38.1±11.2 |124| 38.4±11.0 |104| 39.3±12.1 |46| −1.4±8.1 |45| 3.4±0.8 −0.3±1.0

Tx, treatment.

a

The observed baseline data reflect all records for randomized patients. The observed month 12 data represent patients who provided data at both baseline and month 12. The observed extension data represent patients who provided data at both baseline and during the extended follow-up period, regardless of whether they provided a month 12 measure.

b

For the unadjusted change, numbers are the randomized patients providing baseline, 12-month, and Extension Study measurements. For adjusted results, all available data are used.

c

Results of mixed effects analyses controlling for the baseline level of the factor analyzed, clinical center, and time between baseline and extended follow-up measures.